Current concepts and treatment of digitalis toxicity

Dean T. Mason, Robert Zelis, Garrett Lee, James L. Hughes, James F. Spann, Ezra A. Amsterdam

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Digitalis toxicity is among the most common adverse drug reactions, and may cause arrhythmias and conduction disturbances in as many as 1 of 5 patients. Particularly responsible are the electrophysiologic properties of digitalis in increasing the automaticity of subsidiary pacemakers, reducing the refractory period and prolonging conduction velocity in the atria and ventricles, and delaying conduction in the atrioventricular (A-V) node. Underlying these electrophysiologic effects are digitalis-influenced alterations of cardiac cell transmembrane movements of sodium and potassium; the induction of ectopic impulses due to increased automaticity appears to be caused by inhibition of the activity of the sodium-potassium membrane adenosine triphosphatase (ATPase) pump. Digitalis can provoke every type of cardiac arrhythmia, and no specific disorder of rhythm can be considered absolutely pathognomonic of digitalis toxicity. The factors that predispose to digitalis toxicity, as well as the onset and duration of action of the agent, must be taken into account. Potassium has relatively little influence on the toxic and the contractile actions of digitalis when the cation is administered after the glycoside has been taken up by the myocardium. In contrast, alterations in serum potassium effected before treatment with digitalis may have drastic effects on the electrophysiologic and contractile actions of the glycoside; hyperkalemia reduces the binding of digitalis to the myocardium. Diphenylhydantoin, lidocaine and propranolol are effective in terminating digitalisprovoked tachyarrhythmias, usually without inducing or worsening A-V block. Atrial or ventricular pacing to achieve electrical overdrive of the ectopic focus may be used if standard measures fail. In complete heart block, potassium should not be administered; atropine and electrical pacing should be used.

Original languageEnglish (US)
Pages (from-to)546-559
Number of pages14
JournalThe American journal of cardiology
Volume27
Issue number5
DOIs
StatePublished - Jan 1 1971

Fingerprint

Digitalis
Potassium
Therapeutics
Glycosides
Cardiac Arrhythmias
Myocardium
Toxic Actions
Sodium-Potassium-Exchanging ATPase
Atrioventricular Node
Hyperkalemia
Heart Block
Atrioventricular Block
Phenytoin
Lidocaine
Drug-Related Side Effects and Adverse Reactions
Atropine
Tachycardia
Propranolol
Cell Movement
Cations

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Mason, D. T., Zelis, R., Lee, G., Hughes, J. L., Spann, J. F., & Amsterdam, E. A. (1971). Current concepts and treatment of digitalis toxicity. The American journal of cardiology, 27(5), 546-559. https://doi.org/10.1016/0002-9149(71)90418-8
Mason, Dean T. ; Zelis, Robert ; Lee, Garrett ; Hughes, James L. ; Spann, James F. ; Amsterdam, Ezra A. / Current concepts and treatment of digitalis toxicity. In: The American journal of cardiology. 1971 ; Vol. 27, No. 5. pp. 546-559.
@article{2994bc6298974ce7b1dca06d13b72c6f,
title = "Current concepts and treatment of digitalis toxicity",
abstract = "Digitalis toxicity is among the most common adverse drug reactions, and may cause arrhythmias and conduction disturbances in as many as 1 of 5 patients. Particularly responsible are the electrophysiologic properties of digitalis in increasing the automaticity of subsidiary pacemakers, reducing the refractory period and prolonging conduction velocity in the atria and ventricles, and delaying conduction in the atrioventricular (A-V) node. Underlying these electrophysiologic effects are digitalis-influenced alterations of cardiac cell transmembrane movements of sodium and potassium; the induction of ectopic impulses due to increased automaticity appears to be caused by inhibition of the activity of the sodium-potassium membrane adenosine triphosphatase (ATPase) pump. Digitalis can provoke every type of cardiac arrhythmia, and no specific disorder of rhythm can be considered absolutely pathognomonic of digitalis toxicity. The factors that predispose to digitalis toxicity, as well as the onset and duration of action of the agent, must be taken into account. Potassium has relatively little influence on the toxic and the contractile actions of digitalis when the cation is administered after the glycoside has been taken up by the myocardium. In contrast, alterations in serum potassium effected before treatment with digitalis may have drastic effects on the electrophysiologic and contractile actions of the glycoside; hyperkalemia reduces the binding of digitalis to the myocardium. Diphenylhydantoin, lidocaine and propranolol are effective in terminating digitalisprovoked tachyarrhythmias, usually without inducing or worsening A-V block. Atrial or ventricular pacing to achieve electrical overdrive of the ectopic focus may be used if standard measures fail. In complete heart block, potassium should not be administered; atropine and electrical pacing should be used.",
author = "Mason, {Dean T.} and Robert Zelis and Garrett Lee and Hughes, {James L.} and Spann, {James F.} and Amsterdam, {Ezra A.}",
year = "1971",
month = "1",
day = "1",
doi = "10.1016/0002-9149(71)90418-8",
language = "English (US)",
volume = "27",
pages = "546--559",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "5",

}

Mason, DT, Zelis, R, Lee, G, Hughes, JL, Spann, JF & Amsterdam, EA 1971, 'Current concepts and treatment of digitalis toxicity', The American journal of cardiology, vol. 27, no. 5, pp. 546-559. https://doi.org/10.1016/0002-9149(71)90418-8

Current concepts and treatment of digitalis toxicity. / Mason, Dean T.; Zelis, Robert; Lee, Garrett; Hughes, James L.; Spann, James F.; Amsterdam, Ezra A.

In: The American journal of cardiology, Vol. 27, No. 5, 01.01.1971, p. 546-559.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Current concepts and treatment of digitalis toxicity

AU - Mason, Dean T.

AU - Zelis, Robert

AU - Lee, Garrett

AU - Hughes, James L.

AU - Spann, James F.

AU - Amsterdam, Ezra A.

PY - 1971/1/1

Y1 - 1971/1/1

N2 - Digitalis toxicity is among the most common adverse drug reactions, and may cause arrhythmias and conduction disturbances in as many as 1 of 5 patients. Particularly responsible are the electrophysiologic properties of digitalis in increasing the automaticity of subsidiary pacemakers, reducing the refractory period and prolonging conduction velocity in the atria and ventricles, and delaying conduction in the atrioventricular (A-V) node. Underlying these electrophysiologic effects are digitalis-influenced alterations of cardiac cell transmembrane movements of sodium and potassium; the induction of ectopic impulses due to increased automaticity appears to be caused by inhibition of the activity of the sodium-potassium membrane adenosine triphosphatase (ATPase) pump. Digitalis can provoke every type of cardiac arrhythmia, and no specific disorder of rhythm can be considered absolutely pathognomonic of digitalis toxicity. The factors that predispose to digitalis toxicity, as well as the onset and duration of action of the agent, must be taken into account. Potassium has relatively little influence on the toxic and the contractile actions of digitalis when the cation is administered after the glycoside has been taken up by the myocardium. In contrast, alterations in serum potassium effected before treatment with digitalis may have drastic effects on the electrophysiologic and contractile actions of the glycoside; hyperkalemia reduces the binding of digitalis to the myocardium. Diphenylhydantoin, lidocaine and propranolol are effective in terminating digitalisprovoked tachyarrhythmias, usually without inducing or worsening A-V block. Atrial or ventricular pacing to achieve electrical overdrive of the ectopic focus may be used if standard measures fail. In complete heart block, potassium should not be administered; atropine and electrical pacing should be used.

AB - Digitalis toxicity is among the most common adverse drug reactions, and may cause arrhythmias and conduction disturbances in as many as 1 of 5 patients. Particularly responsible are the electrophysiologic properties of digitalis in increasing the automaticity of subsidiary pacemakers, reducing the refractory period and prolonging conduction velocity in the atria and ventricles, and delaying conduction in the atrioventricular (A-V) node. Underlying these electrophysiologic effects are digitalis-influenced alterations of cardiac cell transmembrane movements of sodium and potassium; the induction of ectopic impulses due to increased automaticity appears to be caused by inhibition of the activity of the sodium-potassium membrane adenosine triphosphatase (ATPase) pump. Digitalis can provoke every type of cardiac arrhythmia, and no specific disorder of rhythm can be considered absolutely pathognomonic of digitalis toxicity. The factors that predispose to digitalis toxicity, as well as the onset and duration of action of the agent, must be taken into account. Potassium has relatively little influence on the toxic and the contractile actions of digitalis when the cation is administered after the glycoside has been taken up by the myocardium. In contrast, alterations in serum potassium effected before treatment with digitalis may have drastic effects on the electrophysiologic and contractile actions of the glycoside; hyperkalemia reduces the binding of digitalis to the myocardium. Diphenylhydantoin, lidocaine and propranolol are effective in terminating digitalisprovoked tachyarrhythmias, usually without inducing or worsening A-V block. Atrial or ventricular pacing to achieve electrical overdrive of the ectopic focus may be used if standard measures fail. In complete heart block, potassium should not be administered; atropine and electrical pacing should be used.

UR - http://www.scopus.com/inward/record.url?scp=0015057112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015057112&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(71)90418-8

DO - 10.1016/0002-9149(71)90418-8

M3 - Article

VL - 27

SP - 546

EP - 559

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 5

ER -